NDC Package 70518-1638-0 Pioglitazone Hydrochloride

Tablet Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is approaching its end of marketing date. An upcoming end of marketing date means the product has been delisted but will remain in the NDC database until the end of marketing date is reached. In most cases, the FDA advises firms to use the expiration date of the last lot produced as the end marketing date, reflecting the possibility that the product may still be available even after manufacturing has stopped.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70518-1638-0
Package Description:
90 TABLET in 1 BOTTLE, PLASTIC
Product Code:
Proprietary Name:
Pioglitazone Hydrochloride
Non-Proprietary Name:
Pioglitazone Hydrochloride
Substance Name:
Pioglitazone Hydrochloride
Usage Information:
Initiation in patients with established NYHA Class III or IV heart failure [see Boxed Warning]. Use in patients with known hypersensitivity to pioglitazone or any other component of pioglitazone tablets.
11-Digit NDC Billing Format:
70518163800
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Remedyrepack Inc.
Dosage Form:
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Sample Package:
No
FDA Application Number:
ANDA200044
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
11-06-2018
End Marketing Date:
10-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70518-1638-0?

The NDC Packaged Code 70518-1638-0 is assigned to a package of 90 tablet in 1 bottle, plastic of Pioglitazone Hydrochloride, a human prescription drug labeled by Remedyrepack Inc.. The product's dosage form is tablet and is administered via oral form.

Is NDC 70518-1638 included in the NDC Directory?

Yes, Pioglitazone Hydrochloride with product code 70518-1638 is active and included in the NDC Directory. The product was first marketed by Remedyrepack Inc. on November 06, 2018.

What is the 11-digit format for NDC 70518-1638-0?

The 11-digit format is 70518163800. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-170518-1638-05-4-270518-1638-00